Αρχική World News Sheriff’s Sergeant Is Now Fighting Stage III Breast Cancer After Missing the...

Sheriff’s Sergeant Is Now Fighting Stage III Breast Cancer After Missing the Early Signs

A Sheriff’s Sergeant from St. John the Baptist Parish, Louisiana, is fighting for her life since being diagnosed with stage III breast cancer. Sherri Wallace‘s friends, family, and colleagues say she has incredible strength and will certainly come out on the other side of this battle.

But Sherri herself is encouraging other people not to ignore the early warning signs like she did.

Sherri first discovered a lump in her breast in January. But she’d just had a normal mammogram a few months prior, so she decided to just monitor it instead of bringing it up with her doctor.

Photo: 4 WWL News

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

By February, the lump had started to become painful and red. In March, she finally decided to have it checked out, and that’s when she received her diagnosis: stage III breast cancer.

“They called me back that Tuesday and let me know that it was breast cancer, and I was in Stage 3,” Sherri remembers. “It had progressed all the way to my lymph nodes. So, you know, I was in need of a round of chemo.”

She actually ended up needing 16 rounds of chemotherapy.

Photo: 4 WWL News

Now Sherri is encouraging other women to check their breasts and not to hesitate to talk to their doctors if anything seems amiss. She also hopes women will be encouraged to get their yearly mammograms.

“It happened, and I’m only 41,” she says. “It’s been a hard journey, but it’s been amazing. It’s a lot of mental work that goes into this. When I first started, I was at home crying, I was in my slump, I wasn’t going anywhere or doing anything. But I’ve learned I am strong, and can do anything.”

Sherri’s family has faith that she’ll get through this, but, all the same, they say it’s hard to watch her go through such a difficult battle.

Photo: 4 WWL News

“It broke my heart, just the way she was feeling, I felt what she felt,” says Cabrina Fleming, Sherri’s sister. “In your natural mind, you’re devastated, just devastating, you don’t know, it’s a big word.”

Lt. Sharon Sealy, a colleague of Sherri’s, also recalls how shocking the news was. “She came by my house, and she told me, and I was breathless for a minute because you never think it’ll hit that close to home. And she was in shock, and she didn’t want anyone to know.”

Sherri serves as something of an inspiration to her family, friends, and coworkers during this time.

Photo: 4 WWL News

“I’m inspired by her strength and how she’s still dedicated,” Sharon said. “Even going through everything, she still asks about her co-workers, about the department. I’m inspired by her completely.”

Cabrina echoes the sentiment. “She’s taught me to never give up, no matter what it is, to keep pushing. Even if you have to move slow, as long as you’re moving forward.”

Check out the video below to learn more about Sherri’s inspiring story.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source


Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...